Eledon Pharmaceuticals Inc. - ELDN Net Assets per Single Share
Eledon Pharmaceuticals (ELDN) develops safe agents for the protection of transplanted organs, although business success depends on clinical trial outcomes and competition with traditional treatment methods. The market trend of share prices with the 0.41 indicator reflects the company's dynamics. The expert team focuses on immunomodulation, combining strict financial control with the advancement of innovations through staged testing.
eledon.com - analytical breakdowns and key metrics (ELDN)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:Eledon - ELDN
Fundamental asset selection is based on the analysis of net assets, which determine the intrinsic value of a business minus all liabilities. This metric measures the actual value of the shareholder's stake, which for Eledon Pharmaceuticals (ELDN), as it implements ethical ESG standards in biopharmaceuticals, confirms capital stability during drug development, reflecting the security of investments through the book value per share trend.
Competitors of Eledon Pharmaceuticals (ELDN)
Argenx (ARGX) - Book Value per Share|BNTX: Equity per Share|Net Assets per Single Share Abivax Corp|ADMA (admabiologics.com) - Equity per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|Net Asset Value per Share AnaptysBio Inc ANAB|ATXS (Astria Pharma) - Book Value per Share|ENGN: Net Asset Value per Share|RAPT Therapeutics, Inc. (RAPT) - Net Assets per Single Share|Aerovate Therapeutics (JBIO) - Net Assets per Single Share|Book Value per Share ACRS (Aclaris Therapeutics, Inc.)|Net Asset Value per Share Kyverna Therapeutics Inc.|Book Value per Share Tiziana Life Sciences PLC TLSA|Equity per Share CABA (Cabaletta Bio Inc)|VTYX: Net Assets per Single Share|theratech.com - Net Asset Value per Share|Avalo Therapeutics (AVTX) - Net Assets per Single Share|Agenus, Inc. (AGEN) - Equity per Share|Accounting Value per Share Climb Bio, Inc. CLYM|ZURA (Zura Bio Ltd) - Accounting Value of a Share|Net Assets per Single Share aTyr Pharma, Inc. ATYR|Share Book Value Adagene Corp|ImageneBio Inc (IMA) - Book Value per Share|Accounting Value of a Share shattucklabs.com (STTK)|Book Value per Share EQ (Equillium)|Connect Biopharma Holdings - Book Value per Share|Net Assets per Single Share Immunic Inc (IMUX)|ATRA: Accounting Value of a Share|IFRX (inflarx.de) - Net Assets per Single Share|X4 Pharmaceuticals Inc. (XFOR) - Accounting Value per Share|ACET (Adicet Bio Inc.) - Book Value per Share|Book Value per Share Celularity Corp|Book Value per Share INMB (INmune Bio, Inc.)|Accounting Value per Share barinthusbio.com (BRNS)|KZR: Book Value per Share|SABS - Net Asset Value per Share|Akari Therapeutics plc - Accounting Value per Share|Enlivex Therapeutics (ENLV) - Book Value per Share|QTTB - Accounting Value per Share|geovax.com (GOVX) - Book Price of a Share|EDSA: Book Value per Share|Net Assets per Share iBio Inc|Book Value per Share CARM (Carisma Therapeutics)|Accounting Value per Share XTL Bio (XTLB)|Book Value per Share BOLT (Bolt Biotherapeutics, Inc.)|HCW Biologics, Inc. - Book Value per Share|APVO - Net Assets per Single Share|AIM: Net Assets per Single Share|aditxt.com - Net Assets per Single Share|GRI Bio Corporation (GRI) - Net Assets per Share|Book Value per Share XRTX (XORTX Therapeutics Inc.)|Net Asset Value per Share HIND|Net Assets per Single Share Revelation Biosciences, Inc. (REVB)|Net Assets per Single Share Indaptus Therapeutics Inc (INDP)|SCNI - Book Value per Share|CalciMedica Inc - Equity per Share|Affimed Therapeutics (AFMD) - Net Assets per Single Share|ALLK: Equity per Share|Net Assets per Single Share hookipapharma.com (HOOK)|IGM Biosciences (IGMS) - Share Book Value|ITOS - Book Value per Share|Accounting Value of a Share Ocean Biomedical Corp|Book Value per Share TCBP|Book Value per Share THRD (thirdharmonicbio.com)